ASHWANOVA™ — ROOT-ONLY ASHWAGANDHA

Root-only. Regulation-ready. Clinically proven.

The only ashwagandha extract built for what the market now demands. USP-standardised root extract, sustained 24-hour release, clinical proof at 150mg — engineered for brand owners who can't afford regulatory risk.

→ Is your formula still compliant? Check in 60 seconds

SCROLL

THE REGULATORY MOMENT

The Ministry drew the line. We've been standing there all along.

India's Ministry of AYUSH has issued an advisory restricting the use of Withania somnifera leaves — in crude form, as extract, or in any other form — across ASU drugs and food supplements marketed in the name of ASU drugs. The ruling cites the Ayurvedic Pharmacopoeia of India, which defines Ashwagandha as the root alone, and the absence of leaves in classical ASU texts. The advisory was formally copied to the CEO of FSSAI.

Ashwanova has been root-only from day one. Not as a reaction. As a founding principle.

For brand owners using leaf-containing extracts, reformulation is now a compliance requirement — not a preference. We're ready to help.

Check your formula in 60 seconds

Source: Ministry of AYUSH Advisory L-11011/9/2021-DCC (PDF)

SINCE DAY ONE

Ashwanova launched root-only

Built on the classical Ayurvedic definition: root is where safety and efficacy live.

MINISTRY OF AYUSH ADVISORY

Leaf-based ashwagandha restricted

Ref L-11011/9/2021-DCC. Only root-based formulations permitted in ASU drugs and food supplements.

TODAY

Brand owners reformulate

Leaf-containing formulations must switch to root-only ingredients to remain compliant.

THE CHALLENGE

Most ashwagandha doesn't go the distance.

Modern stress is constant. So why are most adaptogens dosed for a moment?

74%

of adults report feeling overwhelmed by stress

Source: 2024 APA Stress in America Report

46%

turn to overeating or poor eating habits as a coping mechanism

Source: 2024 APA Stress in America Report

600mg

the standard daily dose of legacy ashwagandha extracts — yet stress and sleep complaints persist

Industry benchmark dose

INTRODUCING

Calm, by design.

Ashwanova™ is a clinically-backed, root-only ashwagandha extract powered by Nutriventia E.D.G.E. — our patented sustained-release platform. One small dose. Twenty-four hours of measurable calm. Zero compromises on purity.

Clean Label CertifiedRoot-OnlyUSP StandardizedGRAS Self-Affirmed100% Natural

THE WEDGE

Why we use only the root.

The root holds the medicinal payload. The leaves carry the regulatory liability. We don't compromise the difference.

INDUSTRY STANDARD

Root + Leaf Extracts

Higher withaferin-A content from leaves — flagged in some EU markets

Inconsistent withanolide profile across batches

Restricted by India's Ministry of AYUSH in ASU drugs and food supplements

Mixed clinical literature on long-term safety at high doses

ASHWANOVA STANDARD

Root Only. Period.

Aligned with Ministry of AYUSH guidance — root-only, matching India's regulatory position on ashwagandha

Standardized to ≥4% USP withanolides — root only

Consistent batch-to-batch verified by LC-MS/MS

GRAS self-affirmed in the U.S., aligned with FDA & EFSA

Two RCTs + pharmacokinetic study published in peer-reviewed journals

"Safety must be guided by science. And now, by regulation."— The Ashwanova Position

THE TECHNOLOGY

One dose. Twenty-four hours. Powered by E.D.G.E.

At the heart of Ashwanova is Nutriventia E.D.G.E. — our patented microbead matrix that releases withanolides in measured bursts over 24 hours. Not all at once. Not in a spike-and-crash. Just sustained, clinically-validated calm.

BIOACTIVE LEVELS — 24 HOURS

Standard Ashwagandha

Ashwanova

Standard @ 8.0h3

Ashwanova @ 8.0h76

DRAG THE CURSOR TO EXPLORE BIOACTIVE LEVELS ACROSS THE DAY

Sustained release

Withanolides released in measured pulses across 24 hours — no peaks, no crashes.

Clean by formulation

No synthetic excipients. No taste maskers. Clean-label compatible globally.

One small dose

150mg or 300mg. Once daily. Half the dose, more measurable benefit.

CLINICAL EVIDENCE

Clinically proven. Repeatedly.

Two randomized, double-blind, placebo-controlled trials. One pharmacokinetic study. All independently published in peer-reviewed journals.

PHARMACOKINETIC STUDY

11.7×

higher bioavailability vs leading competitor extract

Demonstrated 10× more circulating withanolides and a 3.1× longer half-life — the foundation of Ashwanova's 24-hour calm.

Alluri et al., 2022. International Journal of Basic & Clinical Pharmacology.

STRESS, MEMORY & FOCUS

9.3×

reduction in perceived stress score

Also delivered a 1.7× reduction in serum cortisol and 3.5× improvement in sleep quality across the trial period.

Gopukumar et al., 2021. Evidence-Based Complementary and Alternative Medicine.

MULTIDOSE STRESS STUDY

12.7×

reduction in stress-related eating behavior

After 45 days at 300mg: 3.2× reduction in perceived stress, 4.6× improvement in emotional wellbeing, 11.4× improvement in sleep quality.

Thanawala et al., 2025.

Countries

Patents Applied

Patents Granted

Clinical Studies

THE OUTCOMES

One dose. Six outcomes.

Clinically substantiated benefits — measured across multiple validated assessment tools.

Stress Relief

Up to 41.6% reduction in PSS-10 perceived stress scores.

Mood Elevation

Significant improvement in Oxford Happiness Questionnaire scores.

Sleep Quality

PSQI scores improved into the normal range (<5).

Emotional Resilience

Greater capacity to recover from daily stressors.

Cognitive Clarity & Focus

Validated improvements via CANTAB memory and attention tests.

Healthier Eating Behavior

Reduction in stress-driven eating, measured via Three Factor Eating Questionnaire.

FORMATS

Made for every modern format.

Ashwanova's clean-label profile and engineered release platform make it a drop-in fit for the formats consumers actually want.

Tablets

Sustained-release dosing in a familiar pharmaceutical form.

Capsules

Optimized for once-daily compliance.

Gummies

Taste-masked compatibility for chewable formats.

Ready-to-Drink

Stable, dispersible, neutral-tasting.

Stick Packs

On-the-go convenience without flavor compromise.

TRUSTED GLOBALLY

Validated by science. Backed by IP.

Patented in key markets. Standardized to USP. GRAS self-affirmed. Vegan-friendly. Pharma-grade from raw material to final dose.

USP StandardizedGRAS Self-AffirmedFDA-AlignedEFSA-CompatibleVegan-FriendlyClean Label Certified

GLOBAL IP FOOTPRINT — 12 PATENTS GRANTED, 24 PENDING ACROSS 27 MARKETS

QUESTIONS, ANSWERED

What formulators ask us most.

Ashwanova™ is a root-only, sustained-release Ashwagandha extract standardized to 4 percent or more USP withanolides. It is purpose-built using Nutriventia’s patented EDGE™ technology to deliver controlled, all-day withanolide exposure from a single daily dose. Ashwanova™ is engineered to last, not spike, and to remain robust as regulatory and category expectations evolve.

Ashwanova™ is built on first principles. Across Ayurveda, Siddha, and Unani systems, the root of Withania somnifera is the therapeutically relevant part of the plant. Current regulatory frameworks and classical references consistently recognize the root, while guidance around leaf usage remains fragmented across regions. By remaining root-only, Ashwanova™ aligns with tradition, science, and long-term regulatory clarity.

Ashwanova™ takes a clarity-first approach rather than engaging in debate. Leaf-based Ashwagandha lacks consistent historical use, harmonized regulatory acceptance, and long-term clinical positioning across global markets. Ashwanova™ removes this ambiguity entirely by focusing exclusively on the plant part — the root — with enduring therapeutic and regulatory recognition.

Across multiple human clinical studies, Ashwanova™ has demonstrated support for stress reduction, improved sleep quality, enhanced mood, cognitive clarity, emotional resilience, and healthier stress-related eating behavior. These benefits are delivered as comprehensive, all-day stress management from a single low dose.

Ashwanova™ leverages Nutriventia’s EDGE™ microbead matrix to deliver controlled, extended release of withanolides throughout the day. This design avoids sharp concentration spikes and rapid drop-offs, aligning ingredient performance with human stress physiology rather than dosing convenience alone.

Ashwanova™ is supported by three randomized, double-blind, placebo-controlled clinical trials and one human pharmacokinetic study, all published in peer-reviewed journals. Together, these studies demonstrate sustained plasma presence and statistically significant improvements in perceived stress, cortisol levels, sleep quality, and psychological well-being.

Yes. Ashwanova™ works holistically by supporting regulation of cortisol and physiological stress responses, while also improving mood, cognitive performance, and emotional balance. Clinical data also show reductions in stress-related eating behavior, reflecting benefits across both psychological and metabolic dimensions.

Using validated neurocognitive tools such as CANTAB, Ashwanova™ has demonstrated improvements in memory recall, visual memory, and sustained attention. By reducing stress and improving sleep quality, it helps create the conditions necessary for consistent mental clarity and focus.

Ashwanova™ is clinically effective at doses starting at 150 mg once daily, enabled by its enhanced bioavailability and sustained-release design. Its clean-label, low-dose profile makes it suitable for a wide range of formats including capsules, tablets, gummies, stick packs, and ready-to-drink applications.

Yes. Ashwanova™ is GRAS self-affirmed, USP standardized, and Clean Label Project certified. It is designed to align with FDA, EFSA, and emerging global regulatory expectations. Its root-only design reduces reinterpretation risk as compliance frameworks continue to evolve, making it a durable choice for globally scalable formulations.

LET'S BUILD

Let's launch your next hero product.

From compliance check to commercial launch — we partner with brand owners reformulating for the root-only era.

→ Not sure if your current formula is compliant? Check in 60 seconds